Results 31 to 40 of about 204,625 (386)

Class effects of SGLT2 inhibitors in mouse cardiomyocytes and hearts: inhibition of Na+/H+ exchanger, lowering of cytosolic Na+ and vasodilation

open access: yesDiabetologia, 2017
Aims/hypothesisSodium–glucose cotransporter 2 (SGLT2) inhibitors (SGLT2i) constitute a novel class of glucose-lowering (type 2) kidney-targeted agents. We recently reported that the SGLT2i empagliflozin (EMPA) reduced cardiac cytosolic Na+ ([Na+]c) and ...
L. Uthman   +10 more
semanticscholar   +1 more source

Vanillin Induces Relaxation in Rat Mesenteric Resistance Arteries by Inhibiting Extracellular Ca2+ Influx

open access: yesMolecules, 2022
Vanillin is a phenolic aldehyde, which is found in plant species of the Vanilla genus. Although recent studies have suggested that vanillin has various beneficial properties, the effect of vanillin on blood vessels has not been studied well.
Sooyeon Choi   +5 more
doaj   +1 more source

Episcleral Venous Pressure and the Ocular Hypotensive Effects of Topical and Intracameral Prostaglandin Analogs. [PDF]

open access: yes, 2019
There is a limit beyond which increasing either the concentration of a prostaglandin analog (PGA) or its dosing frequency fails to produce increases in ocular hypotensive efficacy with topical dosing.
Alm   +36 more
core   +2 more sources

Effect of a Strategy of Comprehensive Vasodilation vs Usual Care on Mortality and Heart Failure Rehospitalization Among Patients With Acute Heart Failure: The GALACTIC Randomized Clinical Trial.

open access: yesJournal of the American Medical Association (JAMA), 2019
Importance Short-term infusions of single vasodilators, usually given in a fixed dose, have not improved outcomes in patients with acute heart failure (AHF).
N. Kozhuharov   +28 more
semanticscholar   +1 more source

Efficacy and safety of oral pulmonary vasodilators in pulmonary veno‐occlusive disease

open access: yesPulmonary Circulation, 2022
Pulmonary veno‐occlusive disease (PVOD) or pulmonary capillary hemangiomatosis (PCH) is a rare subtype of pulmonary hypertension with dismal prognosis.
Junichi Nakamura   +12 more
doaj   +1 more source

Multidisciplinary Consideration of Potential Pathophysiologic Mechanisms of Paradoxical Erythema with Topical Brimonidine Therapy. [PDF]

open access: yes, 2016
Rosacea is a chronic inflammatory disease with transient and non-transient redness as key characteristics. Brimonidine is a selective α2-adrenergic receptor (AR) agonist approved for persistent facial erythema of rosacea based on significant efficacy and
Detmar, Michael   +6 more
core   +2 more sources

A Critical Role for Astrocytes in Hypercapnic Vasodilation in Brain

open access: yesJournal of Neuroscience, 2017
Cerebral blood flow (CBF) is controlled by arterial blood pressure, arterial CO2, arterial O2, and brain activity and is largely constant in the awake state.
C. Howarth   +13 more
semanticscholar   +1 more source

Current concepts of active vasodilation in human skin

open access: yesTemperature, 2016
In humans, an increase in internal core temperature elicits large increases in skin blood flow and sweating. The increase in skin blood flow serves to transfer heat via convection from the body core to the skin surface while sweating results in ...
B. Wong, Casey G. Hollowed
semanticscholar   +1 more source

Hydrogen sulfide-induced vasodilation mediated by endothelial TRPV4 channels.

open access: yesAmerican Journal of Physiology. Heart and Circulatory Physiology, 2016
Hydrogen sulfide (H2S) is a recently described gaseous vasodilator produced within the vasculature by the enzymes cystathionine γ-lyase and 3-mercaptopyruvate sulfurtransferase.
J. Naik, J. Osmond, B. Walker, N. Kanagy
semanticscholar   +1 more source

Searching the ideal inhaled vasodilator: From nitric oxide to prostacyclin [PDF]

open access: yes, 2002
Today, the technique to directly administer vasodilators via the airway to treat pulmonary hypertension and to improve pulmonary gas exchange is widely accepted among clinicians.
Habler, Oliver   +5 more
core   +1 more source

Home - About - Disclaimer - Privacy